RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
#DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indicates that patients who experienced severe hypoglycaemia were particularly at greater risk of death short term after a severe event https://
I'm reading this on #springerlink https://t.co/nuDcbzDWRS
RT @SFDiabete: L’étude DEVOTE 3 (glargine 100 U/ml vs degludec) montre un risque plus élevé de mortalité toute cause à court et moyen terme…
RT @SFDiabete: L’étude DEVOTE 3 (glargine 100 U/ml vs degludec) montre un risque plus élevé de mortalité toute cause à court et moyen terme…
L’étude DEVOTE 3 (glargine 100 U/ml vs degludec) montre un risque plus élevé de mortalité toute cause à court et moyen terme (15 à 365 jours) chez les sujets DT2 qui ont présenté une hypoglycémie sévère : facteur causal ou marqueur de risque ? #diabète ht
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
In 🇨🇦 @CADTH_ACMTS recommends SU as second line, insulin third line, eschews incretin therapy, thereby ensuring more #hypoglycemia & AEs for PPL#T2D Shameful https://t.co/Yz8ayXnw3v
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
#DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indicates that patients who experienced severe hypoglycaemia were particularly at greater risk of death short term after a severe event https://
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @dramritaghosh: I'm reading this on #springerlink https://t.co/8EpqobxvJj. All cause mortality increases after severe hypoglycaemia . #d…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
@DiabetologiaJnl @hstaceyhn https://t.co/hPHi40E4mi Higher risk of all-cause mortality any time following severe hypoglycaemia. HR: 2,51 (1,79-3,50) in #DEVOTE-3 https://t.co/69SFCviqsC
@DiabetologiaJnl @hstaceyhn https://t.co/hPHi40E4mi Higher risk of all-cause mortality any time following severe hypoglycaemia. HR: 2,51 (1,79-3,50) in #DEVOTE-3 https://t.co/XujW8TyWNX
I'm reading this on #springerlink https://t.co/8EpqobxvJj. All cause mortality increases after severe hypoglycaemia . #diabetes treatment goals should be #individualised so prevent #severe #hypoglycaemia and achieve better #glycemic #control .
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
RT @DiabetologiaJnl: #DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indica…
#DEVOTE demonstrates an association between severe #hypoglycaemia and all-cause #mortality. Furthermore, DEVOTE indicates that patients who experienced severe hypoglycaemia were particularly at greater risk of death short term after a severe event https://
Glycaemic variability, hypoglycaemia, cardiovascular disease and mortality in T2 #diabetes @obsmuk @obsmchat @obsmmex https://t.co/dhVZQSVQaW https://t.co/dafIAH9DYS
RT @SEDiabetes: DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality https://t.co/ykZqeVzd2…
RT @SEDiabetes: DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality https://t.co/ykZqeVzd2…
RT @SEDiabetes: DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality https://t.co/ykZqeVzd2…
RT @SEDiabetes: DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality https://t.co/ykZqeVzd2…
RT @SEDiabetes: DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality https://t.co/ykZqeVzd2…
RT @SEDiabetes: DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality https://t.co/ykZqeVzd2…
RT @SEDiabetes: DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality https://t.co/ykZqeVzd2…
RT @SEDiabetes: DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality https://t.co/ykZqeVzd2…
RT @SEDiabetes: DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality https://t.co/ykZqeVzd2…
RT @SEDiabetes: DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality https://t.co/ykZqeVzd2…
RT @SEDiabetes: DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality https://t.co/ykZqeVzd2…
RT @SEDiabetes: DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality https://t.co/ykZqeVzd2…
RT @SEDiabetes: DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality https://t.co/ykZqeVzd2…
RT @SEDiabetes: DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality https://t.co/ykZqeVzd2…
RT @SEDiabetes: DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality https://t.co/ykZqeVzd2…
RT @SEDiabetes: DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality https://t.co/ykZqeVzd2…
RT @SEDiabetes: DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality https://t.co/ykZqeVzd2…
RT @SEDiabetes: DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality https://t.co/ykZqeVzd2…
RT @SEDiabetes: DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality https://t.co/ykZqeVzd2…
DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality https://t.co/ykZqeVzd2L https://t.co/QDvmLZErav
RT @RpratleyMD: DEVOTE 3: temporal relationships between severe hypoglycemia, cardiovascular outcomes and mortality. - PubMed - NCBI https:…
RT @RpratleyMD: DEVOTE 3: temporal relationships between severe hypoglycemia, cardiovascular outcomes and mortality. - PubMed - NCBI https:…
DEVOTE 3: temporal relationships between severe hypoglycemia, cardiovascular outcomes and mortality. - PubMed - NCBI https://t.co/OLx1KCktNw
RT @Cristob_Morales: https://t.co/hPHi40E4mi Relación entre Hipoglucemia Grave y Mortalidad total en #CSEEN2017 resultados del DEVOTE-3 htt…
RT @Cristob_Morales: https://t.co/hPHi40E4mi Relación entre Hipoglucemia Grave y Mortalidad total en #CSEEN2017 resultados del DEVOTE-3 htt…
RT @Cristob_Morales: https://t.co/hPHi40E4mi Relación entre Hipoglucemia Grave y Mortalidad total en #CSEEN2017 resultados del DEVOTE-3 htt…
RT @Cristob_Morales: https://t.co/hPHi40E4mi Relación entre Hipoglucemia Grave y Mortalidad total en #CSEEN2017 resultados del DEVOTE-3 htt…
RT @Cristob_Morales: https://t.co/hPHi40E4mi Relación entre Hipoglucemia Grave y Mortalidad total en #CSEEN2017 resultados del DEVOTE-3 htt…
RT @Cristob_Morales: https://t.co/hPHi40E4mi Relación entre Hipoglucemia Grave y Mortalidad total en #CSEEN2017 resultados del DEVOTE-3 htt…
RT @Cristob_Morales: https://t.co/hPHi40E4mi Relación entre Hipoglucemia Grave y Mortalidad total en #CSEEN2017 resultados del DEVOTE-3 htt…
RT @Cristob_Morales: https://t.co/hPHi40E4mi Relación entre Hipoglucemia Grave y Mortalidad total en #CSEEN2017 resultados del DEVOTE-3 htt…
RT @Cristob_Morales: https://t.co/hPHi40E4mi Relación entre Hipoglucemia Grave y Mortalidad total en #CSEEN2017 resultados del DEVOTE-3 htt…